Open AccessPrognostic Factors and Morbidities After Completion Surgery in Patients Undergoing Initial Chemoradiation Therapy for Locally Advanced Cervical Cancer
Author(s) -
Touboul Cyril,
Uzan Catherine,
Mauguen Audrey,
Gouy Sebastien,
Rey Annie,
Pautier Patricia,
Lhommé Catherine,
Duvillard Pierre,
HaieMeder Christine,
Morice Philippe
Publication year - 2010
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2009-0295
Subject(s) - medicine , cervical cancer , concomitant , radiation therapy , radical hysterectomy , brachytherapy , hysterectomy , cervix , stage (stratigraphy) , surgery , hazard ratio , chemoradiotherapy , radiology , cancer , confidence interval , paleontology , biology
Learning Objectives After completing this course, the reader will be able to: Rate the prognostic factors for overall survival in patients undergoing completion surgery after initial chemoradiation therapy (CRT) for locally advanced cervical cancer. In cervical cancer patients undergoing completion surgery, consider using laparoscopy to decrease the morbidity of the surgery. In cervical cancer patients undergoing completion surgery, use PET‐CT imaging to improve detection of para‐aortic involvement.This article is available for continuing medical education credit at CME.TheOncologist.comPurpose. The aim of this study was to evaluate the prognostic factors and morbidities of patients undergoing completion surgery for locally advanced‐stage cervical cancer after initial chemoradiation therapy (CRT). Patients and Methods. Patients fulfilling the following inclusion criteria were studied: stage IB2–IVA cervical carcinoma, tumor initially confined to the pelvic cavity on conventional imaging, pelvic external radiation therapy with delivery of 45 Gy to the pelvic cavity and concomitant chemotherapy (cisplatin, 40 mg/m 2 per week) followed by uterovaginal brachytherapy, and completion surgery after the end of radiation therapy including at least a hysterectomy. Results. One‐hundred fifty patients treated in 1998–2007 fulfilled the inclusion criteria. Prognostic factors for overall survival in the multivariate analysis were the presence and level of nodal spread (positive pelvic nodes alone: hazard ratio [HR], 2.03; positive para‐aortic nodes: HR, 5.46; p < .001) and the presence and size of residual disease (RD) in the cervix ( p = .02). Thirty‐seven (25%) patients had 55 postoperative complications. The risk for complications was higher with a radical hysterectomy ( p = .04) and the presence of cervical RD ( p = .01). Conclusion. In this series, the presence and size of RD and histologic nodal involvement were the strongest prognostic factors. Such results suggest that the survival of patients treated using CRT for locally advanced cervical cancer could potentially be enhanced by improving the rate of complete response in the irradiated area (cervix or pelvic nodes) and by initially detecting patients with para‐aortic spread so that treatment could be adapted in such patients. The morbidity of completion surgery is high in this context.